Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112


Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.

Pavuluri MN, Passarotti AM, Lu LH, Carbray JA, Sweeney JA.

Psychiatry Res. 2011 Jul 30;193(1):28-37. doi: 10.1016/j.pscychresns.2011.01.005. Epub 2011 May 17.


Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.

Pavuluri MN, Passarotti AM, Fitzgerald JM, Wegbreit E, Sweeney JA.

J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):157-170.e5. doi: 10.1016/j.jaac.2011.10.019. Epub 2011 Dec 23.


Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.

Pavuluri MN, Ellis JA, Wegbreit E, Passarotti AM, Stevens MC.

Behav Brain Res. 2012 Jan 15;226(2):493-503. doi: 10.1016/j.bbr.2011.10.003. Epub 2011 Oct 8.


Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.

Pavuluri MN, Henry DB, Findling RL, Parnes S, Carbray JA, Mohammed T, Janicak PG, Sweeney JA.

Bipolar Disord. 2010 Sep;12(6):593-605. doi: 10.1111/j.1399-5618.2010.00850.x.


A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder.

Pavuluri MN, Passarotti AM, Parnes SA, Fitzgerald JM, Sweeney JA.

J Child Adolesc Psychopharmacol. 2010 Oct;20(5):395-406. doi: 10.1089/cap.2009.0105.


A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.

Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P.

Arch Gen Psychiatry. 2012 May;69(5):515-28. doi: 10.1001/archgenpsychiatry.2011.1508. Epub 2012 Jan 2.


Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.

Passarotti AM, Sweeney JA, Pavuluri MN.

Psychopharmacology (Berl). 2011 Aug;216(4):485-99. doi: 10.1007/s00213-011-2243-2. Epub 2011 Mar 10.


Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.

Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, Walkup JT, Luby J, Birmaher B, Ryan ND, Emslie G, Robb A, Tillman R.

J Am Acad Child Adolesc Psychiatry. 2012 Sep;51(9):867-78. doi: 10.1016/j.jaac.2012.07.001. Epub 2012 Jul 31.


Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.

Bahk WM, Shin YC, Woo JM, Yoon BH, Lee JS, Jon DI, Chung SK, Choi SK, Paik IH, Pae CU.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):115-21. Epub 2004 Nov 19.


Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.

Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A.

Br J Psychiatry. 2003 Feb;182:141-7. Erratum in: Br J Psychiatry. 2003 Apr;182:369.


Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.

West AE, Weinstein SM, Celio CI, Henry D, Pavuluri MN.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):545-53. doi: 10.1089/cap.2010.0140. Epub 2011 Dec 2.


Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder.

Pavuluri MN, Passarotti AM, Harral EM, Sweeney JA.

J Clin Psychiatry. 2010 Nov;71(11):1526-34. doi: 10.4088/JCP.09m05504yel. Epub 2010 Aug 24.


Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.

Kowatch RA, Scheffer RE, Monroe E, Delgado S, Altaye M, Lagory D.

J Child Adolesc Psychopharmacol. 2015 May;25(4):306-13. doi: 10.1089/cap.2014.0166.


An fMRI study of the neural correlates of incidental versus directed emotion processing in pediatric bipolar disorder.

Pavuluri MN, Passarotti AM, Harral EM, Sweeney JA.

J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):308-19. doi: 10.1097/CHI.0b013e3181948fc7.


Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder.

Wegbreit E, Ellis JA, Nandam A, Fitzgerald JM, Passarotti AM, Pavuluri MN, Stevens MC.

Brain Connect. 2011;1(5):411-22. doi: 10.1089/brain.2011.0035. Epub 2011 Dec 7.


Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.

Walkup JT, Wagner KD, Miller L, Yenokyan G, Luby JL, Joshi PT, Axelson DA, Robb A, Salpekar JA, Wolf D, Sanyal A, Birmaher B, Vitiello B, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 2015 Dec;54(12):1008-19. doi: 10.1016/j.jaac.2015.09.015. Epub 2015 Oct 8.


A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.

Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):519-32. doi: 10.1097/CHI.0b013e31819c55ec.


Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.

Ouyang WC, Hsu MC, Yeh IN, Kuo CC.

Int J Psychiatry Clin Pract. 2012 Sep;16(3):178-88. doi: 10.3109/13651501.2011.644564. Epub 2012 Mar 9.


A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.

Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vågerö M.

Int Clin Psychopharmacol. 2007 Jul;22(4):212-20.


Supplemental Content

Support Center